Steger, GG; Greil, R; Jakesz, R; Lang, A; Mlineritsch, B; Rudas, M; Marth, C; Stoeger, H; Singer, CF; Gnant, M.
Independent prognostic factors for response: updated results of the ABCSG-24 study evaluating the addition of capecitabine to epirubicin-docetaxel neoadjuvant therapy for early breast cancer (EBC)
EJC SUPPL. 2010; 8(3): 60-60.
Doi: 10.1016/S1359-6349(10)70040-9
[Poster]
Web of Science
FullText
FullText_MUG